
View larger version (39K):
[in a new window]
|
Fig. 3. Inhibition of Smicl function causes down regulation of Chordin
expression, but not of other mesodermal and endodermal markers. (A-E)
Expression levels, normalised to that of ornithine decarboxylase, of
Xbra (A), Sox17 (B), Xnr3 (C), Goosecoid
(D) and Chordin (E) in uninjected embryos, embryos injected with
morpholino oligonucleotide coMO (80 ng), or embryos injected with morpholino
oligonucleotide XlMO (80 ng). RNA was extracted at the indicated stages, and
RNA levels were analysed by quantitative RT-PCR. (F,G) Inhibition of Smicl
function by means of morpholino oligonucleotide XtMO1 (5 ng; F) or XtMO2 (30
ng; G) also causes downregulation of Chordin expression in
Xenopus tropicalis. Embryos were assayed at stages 9, 9.5, 10 and
10.5 (F), or at stage 10.5 (G). (H) Injection of RNA encoding mouse Smicl
causes the upregulation of Chordin in embryos injected with
morpholino oligonucleotide coMO and rescues the downregulation of
Chordin caused by morpholino oligonucleotide XlMO. Embryos were
injected with the indicated RNAs (1 ng) or morpholino oligonucleotides (50
ng). RNA was extracted at stage 10.5 and expression of Chordin and
ornithine decarboxylase was assayed by quantitative RT-PCR. (I) In
situ hybridisation of Xenopus laevis embryos at the early gastrula
stage confirms that inhibition of Smicl function causes the downregulation of
Chordin. The embryo on the left was injected with coMO (80 ng;
n=15) and the one on the right with XlMO (80 ng; n=15). (J)
Injection of Chordin mRNA can partially rescue the phenotype caused
by XlMO. Numbers indicate how many embryos out of 50 display this
phenotype.
|